The IGF‐I regulatory system and its impact on skeletal and energy homeostasis

Insulin‐like growth factor (IGF)‐I is important in the acquisition and maintenance of both soft and hard tissues. Skeletal remodeling requires energy and recent work has demonstrated that bone can influence insulin sensitivity and thereby regulate metabolic processes. New insights from mouse models into the role of IGF‐binding proteins (IGFBPs) as more than mere depots for the IGFs has reignited investigations into the metabolic targets influenced by the IGF regulatory system and the pathways that link bone to adipose tissue. Although there remains continued uncertainty about the relative balance between the effects of circulating versus tissue IGF‐I actions, the role of the IGFBPs has been redefined both as modulators of IGF‐I action and as independent signaling factors. This review highlights several recent findings that shed new light on the physiologic role of the IGF regulatory system and its influence on skeletal and fat metabolism. J. Cell. Biochem. 111: 14–19, 2010. © 2010 Wiley‐Liss, Inc.

[1]  L. Donahue,et al.  A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis. , 2010, The Journal of endocrinology.

[2]  S. Yakar,et al.  Elevated Serum Levels of IGF-1 Are Sufficient to Establish Normal Body Size and Skeletal Properties Even in the Absence of Tissue IGF-1 , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  H. Sul.  Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate. , 2009, Molecular endocrinology.

[4]  S. Cummings,et al.  Serum Insulin‐Like Growth Factor‐1 Binding Proteins 1 and 2 and Mortality in Older Adults: The Health, Aging, and Body Composition Study , 2009, Journal of the American Geriatrics Society.

[5]  C. Rosen,et al.  Insulin-like growth factor-I and bone: lessons from mice and men , 2009, Pediatric Nephrology.

[6]  R. Baxter,et al.  Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3. , 2009, American journal of physiology. Endocrinology and metabolism.

[7]  H. Ariga,et al.  PAPA-1 Is a nuclear binding partner of IGFBP-2 and modulates its growth-promoting actions. , 2009, Molecular endocrinology.

[8]  A. Efstratiadis,et al.  The hormonal action of IGF1 in postnatal mouse growth , 2008, Proceedings of the National Academy of Sciences.

[9]  L. Kuller,et al.  Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults. , 2008, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[10]  K. Schmitz,et al.  Interactions between Insulin, Body Fat, and Insulin-Like Growth Factor Axis Proteins , 2007, Cancer Epidemiology Biomarkers & Prevention.

[11]  Antonio Vidal-Puig,et al.  IGF-Binding Protein-2 Protects Against the Development of Obesity and Insulin Resistance , 2007, Diabetes.

[12]  O. MacDougald,et al.  Adipocyte differentiation from the inside out , 2006, Nature Reviews Molecular Cell Biology.

[13]  C. Rosen,et al.  Postnatal growth and bone mass in mice with IGF-I haploinsufficiency. , 2006, Bone.

[14]  S. Corroyer,et al.  Intracellular colocalization and interaction of IGF-binding protein-2 with the cyclin-dependent kinase inhibitor p21CIP1/WAF1 during growth inhibition. , 2005, The Biochemical journal.

[15]  L. Melton,et al.  A Potentially Deleterious Role of IGFBP‐2 on Bone Density in Aging Men and Women , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  D. Powell,et al.  Perturbations in Bone Formation and Resorption in Insulin‐Like Growth Factor Binding Protein‐3 Transgenic Mice , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  K. Kristiansen,et al.  Insulin-like Growth Factor-1/Insulin Bypasses Pref-1/FA1-mediated Inhibition of Adipocyte Differentiation* , 2003, Journal of Biological Chemistry.

[18]  Jennifer Skeen,et al.  Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. , 2003, Genes & development.

[19]  D. Grobbee,et al.  Serum insulin-like growth factor binding protein-2 levels as an indicator of functional ability in elderly men. , 2003, European journal of endocrinology.

[20]  T. Clemens,et al.  Paracrine Overexpression of IGFBP‐4 in Osteoblasts of Transgenic Mice Decreases Bone Turnover and Causes Global Growth Retardation , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[22]  M. Bouxsein,et al.  Osteoblast-specific Knockout of the Insulin-like Growth Factor (IGF) Receptor Gene Reveals an Essential Role of IGF Signaling in Bone Matrix Mineralization* , 2002, The Journal of Biological Chemistry.

[23]  E. Canalis,et al.  Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia. , 2002, Endocrinology.

[24]  D. Leroith,et al.  Circulating levels of IGF-1 directly regulate bone growth and density. , 2002, The Journal of clinical investigation.

[25]  M. Westwood,et al.  IGF-binding protein-1 inhibits IGF effects on adipocyte function: implications for insulin-like actions at the adipocyte. , 2002, The Journal of endocrinology.

[26]  S. Khosla,et al.  Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. , 2002, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[27]  D. Dunger,et al.  Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study , 2002, The Lancet.

[28]  Martin Holzenberger,et al.  Experimental IGF-I Receptor Deficiency Generates a Sexually Dimorphic Pattern of Organ-Specific Growth Deficits in Mice, Affecting Fat Tissue in Particular. , 2001, Endocrinology.

[29]  Y. Terauchi,et al.  Essential Role of Insulin Receptor Substrate 1 (IRS-1) and IRS-2 in Adipocyte Differentiation , 2001, Molecular and Cellular Biology.

[30]  K. Chihara,et al.  Determinants of Bone Mineral Density and Spinal Fracture Risk in Postmenopausal Japanese Women , 2001, Osteoporosis International.

[31]  A. Hoeflich,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Growth Inhibition in Giant Growth Hormone Transgenic Mice by Overexpression of Insulin-Like Growth Factor- Binding Protein-2 , 2000 .

[32]  W. Zhao,et al.  Expressions of leptin and insulin-like growth factor-I are highly correlated and region-specific in adipose tissue of growing rats. , 2000, Obesity research.

[33]  L. Donahue,et al.  Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. , 2000, Endocrinology.

[34]  P. Gruppuso,et al.  The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes. , 2000, Molecular endocrinology.

[35]  P. Delmas,et al.  Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women , 2000, The Lancet.

[36]  R. Martin,et al.  Insulin-like growth factor I mediates high-fat diet-induced adipogenesis in Osborne-Mendel rats. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[37]  B. Spiegelman,et al.  Molecular regulation of adipogenesis. , 2000, Annual review of cell and developmental biology.

[38]  V. Hwa,et al.  The Insulin-like Growth Factor-binding Protein (igfbp) Superfamily* , 2022 .

[39]  T. Modric,et al.  Impaired adipogenesis in insulin-like growth factor binding protein-1 transgenic mice. , 1999, The Journal of endocrinology.

[40]  D. Leroith,et al.  Normal growth and development in the absence of hepatic insulin-like growth factor I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Kiel,et al.  Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. , 1998, The Journal of clinical endocrinology and metabolism.

[42]  S. Khosla,et al.  Insulin-Like Growth Factor System Abnormalities in Hepatitis C-Associated Osteosclerosis , 1998 .

[43]  C. Christoffersen,et al.  Insulin and insulin-like growth factor-I receptor mediated differentiation of 3T3-F442A cells into adipocytes: effect of PI 3-kinase inhibition. , 1998, Biochemical and biophysical research communications.

[44]  S. Khosla,et al.  Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults. , 1998, The Journal of clinical investigation.

[45]  P. Gruppuso,et al.  Modulation of insulin-like growth factor I mitogenic signaling in 3T3-L1 preadipocyte differentiation. , 1998, Endocrinology.

[46]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[47]  G. Werther,et al.  Identification, localization, and regulation of insulin-like growth factor binding proteins and their messenger ribonucleic acids in the newborn rat olfactory bulb. , 1994, Endocrinology.

[48]  L. Donahue,et al.  Insulin-like Growth Factors and Bone: The Osteoporosis Connection , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[49]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[50]  P. Smith,et al.  Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. , 1988, The Journal of biological chemistry.